Campbell & Co. Investment Adviser »

Krystal Biotech shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.6M 18k 258.32
2025-09-30 $304k 1.7k 176.53
2025-06-30 $274k 2.0k 137.46
2024-03-31 $441k 2.5k 177.93

More positions owned by Campbell & Co. Investment Adviser

Bank of Nova Scotia/The Common Stock (BNS)
Shell Adr (SHEL)
Illinois Tool Works Common Stock (ITW)
Williams Cos Inc/The Common Stock (WMB)
Alphabet Common Stock (GOOGL)
Phillips 66 Common Stock (PSX)
Murphy Oil Corp Common Stock (MUR)
Teledyne Technologies Common Stock (TDY)
Nordson Corp Common Stock (NDSN)
Agilent Technologies Common Stock (A)
EQT Corp Common Stock (EQT)
Expand Energy Corp Common Stock (EXE)
Atmos Energy Corp Common Stock (ATO)
Chevron Corp Common Stock (CVX)
Baker Hughes Common Stock (BKR)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Group
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Redmile Group
Geode Capital Management
Hood River Capital Management
Frazier Life Sciences Management
Dimensional Fund Advisors
Bellevue Group

View all funds holding Krystal Biotech